Hello readers! Today we have an exciting story to share with you. Scientists from the University of Mississippi have recently made a breakthrough in the field of drug delivery for cervical cancer patients. But before we dive into the details, let’s take a moment to think about the traditional methods of drug administration.
For many years, oral medication has been the most common route for delivering drugs to patients. However, this method often presents issues with absorption, side effects, and may not always be favored by patients. That’s why researchers at the University of Mississippi decided to explore a different approach.
Enter Eman Ashour, assistant professor of pharmaceutics and drug delivery, and researcher Ahmed Almotairy. Their primary focus was on a drug called disulfiram, which was previously used for treating alcoholism but has shown potential in treating various cancers. The team wanted to find a better way to deliver this drug to cervical cancer patients.
To achieve their goal, the researchers combined two innovative techniques: hot-melt extrusion (HME) and 3D printing. HME is a process that reshapes materials after they have melted, and the scientists used it to create drug-laden filaments. These filaments were then used in 3D printing to create patient-specific doses of the drug.
However, there was a challenge to overcome. Disulfiram is heat-sensitive, which posed difficulties for its vaginal administration. But the researchers were not deterred. Through refinements in the drug’s design and modulation of HME processing temperatures, they were able to create a vaginal film that successfully delivered the drug to the cervix.
This breakthrough has the potential to revolutionize drug delivery for cervical cancer patients. By targeting medication delivery to the cervix via the vagina, the researchers have created a more effective and patient-friendly method of treatment. Assistant professor Eman Ashour believes that this study will contribute to improving patient outcomes and treatment alternatives.
But the implications of this research go beyond cervical cancer. The same technology could be applied to the vaginal delivery of other drugs, such as antifungal, antimicrobial, anti-cancer, and hormone medications. This opens up new possibilities for treating a wide range of diseases and conditions.
So what’s next for the team at the University of Mississippi? According to Ashour, they hope to build new technologies based on the success of this project and explore other disease states and uses in the future. The potential for this technology is vast, and it’s exciting to think about the advancements it could bring to the field of medicine.
We would love to hear your thoughts on this groundbreaking research. Join the conversation on our Facebook, Twitter, and LinkedIn pages. And don’t forget to sign up for our weekly additive manufacturing newsletter to stay up to date with the latest stories in the field.
